← All trials
NCT03267784
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 21, 2017
- Primary completion
- Mar 31, 2019
- Completion date
- Dec 31, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 37
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Rheacell GmbH & Co. KGLead sponsor
- FGK Clinical Research GmbHCollaborator
- Granzer Regulatory Consulting & ServicesCollaborator
- TICEBA GmbHCollaborator
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie, Würzburg, GermanyOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.